VectorY Therapeutics
fund manager
sector
Healthcare
geography
Europe
Vintages
status
Portfolio
category
#ImpactPositive

VectorY Therapeutics

Co-invested company
VectorY Therapeutics is a leading biotechnology company focused on the discovery and development of innovative therapies for the treatment of rare genetic diseases.
Building for VectorY Therapeutics, part of the Private Equity manager's portfolio Insight Partners

Key figures for VectorY Therapeutics

2020
year established
138 M$
raised in 2023
+ 100
employees
38 M$
raised in 2021
*Source: Public data from company websites and social networks. For the most up-to-date information, we invite our investors to consult the reports available in their own space.

About VectorY Therapeutics

With its expertise in gene therapy and genome editing, VectorY is transforming patients' lives by offering innovative, targeted treatment solutions.

Based in Amsterdam, VectorY focuses on several therapeutic areas, including neuromuscular diseases, inherited metabolic disorders and rare genetic diseases of the central nervous system.  

VectorY is at the forefront of innovation in the field of gene therapy, offering hope and solutions for patients and their families. The company is committed to providing safe, effective and accessible therapies to meet the unmet medical needs of people suffering from rare genetic diseases.

In the same sector as VectorY Therapeutics

Discover our exclusive services
Insight Partners
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio